Target intelligence / Profile preview

Reactive oxygen species and lipid radicals in phospholipid membranes (ROS/LR)

Target
ROS/LR
Molecular classification
Reactive chemical species, Free radicals, Other
01

Overview

Reactive oxygen species (ROS) and lipid radicals in phospholipid membranes are critical mediators of oxidative stress and cellular damage. ROS, such as hydroxyl radicals and superoxide, initiate lipid peroxidation by abstracting hydrogen atoms from polyunsaturated fatty acids within the lipid bilayer, generating highly reactive lipid peroxyl and alkoxyl radicals (Ayala et al., 2014, Oxidative Medicine and Cellular Longevity). This autocatalytic chain reaction compromises the structural integrity, fluidity, and permeability of biological membranes, eventually leading to regulated cell death pathways like ferroptosis (Dixon et al., 2012, Cell). These reactive species are central to the pathogenesis of numerous conditions, including neurodegenerative diseases like Alzheimer's and cardiovascular disorders like atherosclerosis (Gaschler & Stockwell, 2017, Biochem Biophys Res Commun). Therapeutic targeting involves the use of radical-trapping antioxidants (RTAs) and scavengers that intercept these radicals to terminate the peroxidation chain (Conrad & Pratt, 2019, Nature Chemical Biology). Drugs such as edaravone are clinically utilized to scavenge these radicals in the treatment of amyotrophic lateral sclerosis and stroke, while experimental compounds like ferrostatin-1 are being developed to specifically inhibit lipid radical-mediated ferroptotic damage.

Other names
Reactive oxygen speciesLipid radicalsLipid peroxyl radicalsLipid alkoxyl radicalsOxidative stress mediatorsMembrane lipid peroxides
02

Mechanism of action

Free radical scavenging and chain-breaking antioxidant activity to neutralize reactive species and terminate lipid peroxidation cycles.

03

Biological functions

Signal transductionCell deathLipid peroxidationFerroptosisOther
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseCancerInflammationIschemia-reperfusion injuryOther
05

Safety considerations

Interference with essential physiological redox signalingPotential pro-oxidant activity at high concentrationsPoor metabolic stability and bioavailability of many radical scavengersDifficulty in achieving site-specific membrane localization
06

Interacting drugs

Edaravone

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)8-IsoprostaneF2-isoprostanesProtein carbonyls

Beyond the preview

Go deeper on Reactive oxygen species and lipid radicals in phospholipid membranes (ROS/LR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and lipid radicals in phospholipid membranes (ROS/LR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call